Should third-generation cephalosporins be avoided against AmpC-inducible Enterobacteriaceae?

被引:29
作者
Livermore, DM
Brown, DFJ
Quinn, JP
Carmeli, Y
Paterson, DL
Yu, VL
机构
[1] Cent Publ Hlth Lab, Antibiot Resistance Monitoring & Reference Lab, London NW9 5HT, England
[2] Addenbrookes Hosp, Clin Microbiol & Publ Hlth Lab, Cambridge, England
[3] Cook Cty Hosp, Dept Med, Chicago, IL 60612 USA
[4] Rush Univ, Chicago, IL 60612 USA
[5] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[6] Univ Pittsburgh, Med Ctr, Div Infect Dis, Pittsburgh, PA 15213 USA
[7] VA Med Ctr, Infect Dis Sect, Pittsburgh, PA 15240 USA
关键词
D O I
10.1111/j.1469-0691.2004.00831.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:84 / 85
页数:2
相关论文
共 15 条
  • [1] Imipenem resistance of Enterobacter aerogenes mediated by outer membrane permeability
    Bornet, C
    Davin-Regli, A
    Bosi, C
    Pages, JM
    Bollet, C
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (03) : 1048 - 1052
  • [2] Emergence of antibiotic-resistant Pseudomonas aeruginosa:: Comparison of risks associated with different antipseudomonal agents
    Carmeli, Y
    Troillet, N
    Eliopoulos, GM
    Samore, MH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) : 1379 - 1382
  • [3] ENTEROBACTER BACTEREMIA - CLINICAL-FEATURES AND EMERGENCE OF ANTIBIOTIC-RESISTANCE DURING THERAPY
    CHOW, JW
    FINE, MJ
    SHLAES, DM
    QUINN, JP
    HOOPER, DC
    JOHNSON, MP
    RAMPHAL, R
    WAGENER, MM
    MIYASHIRO, DK
    YU, VL
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (08) : 585 - 590
  • [4] Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species
    Cosgrove, SE
    Kaye, KS
    Eliopoulous, GM
    Carmeli, Y
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (02) : 185 - 190
  • [5] FISH DN, 1995, PHARMACOTHERAPY, V15, P279
  • [6] Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins
    FungTomc, JC
    Gradelski, E
    Huczko, E
    Dougherty, TJ
    Kessler, RE
    Bonner, DP
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (05) : 1289 - 1293
  • [7] Cephalosporinase induction and cephalosporin resistance: a longstanding misinterpretation
    Goldstein, FW
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2002, 8 (12) : 823 - 825
  • [8] THE RELATIONSHIP BETWEEN ANTECEDENT ANTIBIOTIC USE AND RESISTANCE TO EXTENDED-SPECTRUM CEPHALOSPORINS IN GROUP-I BETA-LACTAMASE-PRODUCING ORGANISMS
    JACOBSON, KL
    COHEN, SH
    INCIARDI, JF
    KING, JH
    LIPPERT, WE
    IGLESIAS, T
    VANCOUWENBERGHE, CJ
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 21 (05) : 1107 - 1113
  • [9] Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp.
    Kaye, KS
    Cosgrove, S
    Harris, A
    Eliopoulos, GM
    Carmeli, Y
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (09) : 2628 - 2630
  • [10] Seizures in the critically ill: The role of imipenem
    Koppel, BS
    Hauser, WA
    Politis, C
    van Duin, D
    Daras, M
    [J]. EPILEPSIA, 2001, 42 (12) : 1590 - 1593